Skip to content
← Lobby Directory
FO
Trade & BusinessFarmaForum

Forum of International Research and Development Pharmaceutical Companies, EIG

Ljubljana, SLOVENIAEconomic Interest GroupingReg: 786313251884-04Since 16/11/2023

Budget

€25 — €0

EP Access

0

accredited persons

Staff

1

0.25 FTE

EU Grants

None

Mission & Goals

Forum of International Research and Development Pharmaceutical Companies, EIG (FarmaForum) is a representative of innovative pharmaceutical industry in Slovenia. We connect 22 pharmaceutical companies with a common mission #We WontRest to develop innovative medicines vaccines and therapies that are keys to controlling various diseases and improving the quality of life of patients around the world. FarmaForum operates as a non-governmental, non-profit, non-political and independent economic interest grouping which strives to act as a trusted partner in the field of medicine, health and healthcare in the Slovenian society.

EU Legislative Interests

- Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC - Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006

Communication Activities

Comments to the Commission proposal of the Pharmaceutical Regulation and Pharmaceutical Directive

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

Chamber of Commerce and Industry of Slovenia, https://eng.gzs.si/ EFPIA, https://www.efpia.eu/

Organisation Members

EFPIA, https://www.efpia.eu/

Connected Legislation

Commissioner Meetings

No recorded meetings with EU commissioners.